To L B, Haylock D N, Dyson P G, Thorp D, Roberts M M, Juttner C A
Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia.
Bone Marrow Transplant. 1990 Aug;6(2):109-14.
Fourteen patients with acute myeloid leukemia (AML) were autotransplanted with peripheral blood cells collected during early remission. Seven were autotransplanted in first relapse and seven in first remission. They received a median of 3.3 X 10(8) nucleated cells/kg body weight (BW) and 92 X 10(4) myeloid progenitor cell (CFU-GM) per kg BW. Rapid hemopoietic reconstitution (HR) occurred in all patients with median time to reach normal neutrophil and platelet counts 13 and 18 days post re-infusion respectively. However, in three patients neutrophil counts fell to less than 1.0 x 10(9)/l and in seven patients platelet counts fell to less than 25 x 10(9)/l between 26 and 40 days post-transplant (trough count). In all but two patients who received the lowest CFU-GM dose the counts returned to normal or near normal levels (steady count). There were significant correlations between the CFU-GM dose and the trough and the steady platelet counts (p = 0.04 and 0.01 respectively). Patients receiving more than 50 x 10(4) CFU-GM/kg BW had higher steady neutrophil and platelet counts (p = 0.011 and 0.033 respectively) although some patients receiving greater than 50 x 10(4) CFU-GM/kg still experienced thrombocytopenia during the second month post graft. There was no significant correlation between the nucleated cell dose and HR. The cause of the fall in platelet and neutrophil counts in the second month post graft is not clear but is probably a reflection of a proliferative defect in the recovery phase stem cells in AML.
14例急性髓系白血病(AML)患者在早期缓解期采集外周血细胞进行自体移植。7例在首次复发时进行自体移植,7例在首次缓解期进行自体移植。他们接受的有核细胞中位数为3.3×10⁸个/千克体重(BW),髓系祖细胞(CFU-GM)中位数为92×10⁴个/千克BW。所有患者均出现快速造血重建(HR),中性粒细胞和血小板计数分别在再输注后13天和18天达到正常的中位时间。然而,3例患者中性粒细胞计数在移植后26至40天(低谷计数)降至低于1.0×10⁹/升,7例患者血小板计数降至低于25×10⁹/升。除2例接受最低CFU-GM剂量的患者外,其余患者的计数均恢复到正常或接近正常水平(稳定计数)。CFU-GM剂量与低谷和稳定血小板计数之间存在显著相关性(分别为p = 0.04和0.01)。接受超过50×10⁴个CFU-GM/千克BW的患者稳定中性粒细胞和血小板计数更高(分别为p = 0.011和0.033),尽管一些接受大于50×10⁴个CFU-GM/千克的患者在移植后第二个月仍出现血小板减少。有核细胞剂量与HR之间无显著相关性。移植后第二个月血小板和中性粒细胞计数下降的原因尚不清楚,但可能反映了AML恢复期干细胞的增殖缺陷。